Evolution of systemic treatment for hormone-sensitive breast cancer: from sequential use of single agents to the upfront administration of drug combinations by E. N. Imyanitov

Get full text

CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER by E. N. Imyanitov, T. Yu. Semiglazova

Get full text

Molecular pathology of lung cancer: clinical aspects by I. S. Polyakov, E. N. Imyanitov

Get full text

The role of molecular diagnostics in the choice of therapy for biliary tract cancers by N. V. Mitiushkina, E. N. Imyanitov

Get full text

CLINICAL SIGNIFICANCE OF STUDYING GENETIC POLYMORPHISM OF THE Р450 CYP2C9 AND CYP2C19 DETOXIFYING ENZYME GENES IN EPILEPTIC CHILDREN by O. V. Guzeva, E. N. Imyanitov

Get full text

MOLECULAR-GENETIC «PORTRAIT» OF BREAST CANCER by S. A. Laptiev, M. A. Korzhenevskaia, E. N. Imyanitov

Get full text

Clinical features of BRCA-positive ovarian cancer by S. Ya. Maximov, E. N. Imyanitov, K. D. Guseinov, T. V. Gorodnova

Get full text

GENETICS OF SUSCEPTIBILITY TO INFECTIOUS DISEASES by E. N. Suspitsin, E. Yu. Skripchenko, E. N. Imyanitov, N. V. Skripchenko

Get full text

Pharmacogenomics in pediatric oncology: possibility to overcome drug-induced toxicity of anticancer treatment by Yu. V. Dinikina, E. N. Imyanitov, M. B. Belogurova, I. L. Nikitina

Get full text

Features and complexity of treatment of <i>BRCA</i>-associated ovarian cancer, chronic disease: literature review by T. V. Gorodnova, A. P. Sokolenko, Kh. B. Kotiv, I. V. Berlev, E. N. Imyanitov

Get full text

Hereditary ovarian cancer by Kh. B. Kotiv, T. V. Gorodnova, A. P. Sokolenko, I. V. Berlev, E. N. Imyanitov

Get full text

HRD-negative high-grade carcinoma of the ovary in <i>BRCA2</i> pathogenic variant carrier by A. P. Sokolenko, S. V. Poletaeva, A. D. Shestakova, T. V. Gorodnova, I. V. Berlev, E. N. Imyanitov

Get full text

Tumor immune microenvironment and apoptotic markers in breast cancer patients carrying <I>BRCA1</I> gene mutations by A. I. Stukan, A. Yu. Goryainova, O. Yu. Chukhray, S. D. Maksimenko, E. N. Imyanitov, S. V. Sharov, Z. K. Khachmamuk

Get full text

Reactivaion of immune-related colitis during targeted therapy in a patient with metastatic cutaneous melanoma by E. A. Degtiareva, S. A. Protsenko, E. N. Imyanitov, G. M. Teletaeva, D. Kh. Latipova, A. I. Semenova, A. V. Novik

Get full text

MORPHOLOGIC AND MOLECULAR FEATURES OF PRIMARY GLIOBLASTOMA IN PATIENTS SURVIVING MORE THAN 3 YEARS by M. V. Matsko, D. E. Matsko, N. M. Volkov, A. Yu. Ulitin, V. M. Moiseenko, E. N. Imyanitov, A. G. Iyevleva

Get full text

RADIOTHERAPY IN MANAGEMENT OF BRCA-POSITIVE OVARIAN CANCER by T. V. Gorodnova, S. B. Baranov, L. N. Shevkunov, S. A. Tyatkov, A. P. Sokolenko, C. B. Kotiv, E. N. Imyanitov, I. V. Berlev

Get full text

THE ROLE OF GENETIC FACTORS IN THE DEVELOPMENT OF HERPETIC ENCEPHALITIS. A CASE FROM PRACTICE by A. S. Levina, O. V. Goleva, A. A. Vilnits, R. A. Ivanova, E. N. Suspitsin, N. V. Skripchenko, E. N. Imyanitov, E. Yu. Skripchenko

Get full text

Survival of patients with salivary gland malignancies depending on the molecular profile of the tumor by S. I. Kutukova, E. N. Imyanitov, G. A. Raskin, Yu. V. Ivaskova, N. P. Belyak, A. I. Yaremenko, A. Ya. Razumova, P. M. Baykalova

Get full text

Clinical and prognostic characteristics of <I>BRCA1/2</I>-associated breast cancer depending on the type of mutation: estrogen signaling pathway and secondary tumors by A. I. Stukan, A. Yu. Goryainova, R. A. Murashko, Z. K. Khachmamuk, O. Yu. Chukhray, S. D. Maksimenko, O. A. Goncharova, E. N. Imyanitov, V. A. Porkhanov

Get full text

Predictive and prognostic features of early and locally advanced <i>PIK3CA</i>-mutated luminal HER2-negative breast cancer by A. I. Stukan, T. Yu. Semiglazova, S. I. Kutukova, V. A. Porkhanov, V. N. Bodnya, E. N. Imyanitov, V. V. Antipova, Z. K. Khachmamuk, O. Yu. Chukhray, S. D. Maksimenko

Get full text